Table 3 SABA OTC purchase in the 12 months before the study visit
SABA OTC 12 months before the study visit | All (N = 405) | Primary care (n = 222) | Specialist care (n = 183) | ||||
|---|---|---|---|---|---|---|---|
Mild asthma (n = 208) | Moderate-to-severe asthma (n = 14) | All (n = 222) | Mild asthma (n = 100) | Moderate-to-severe asthma (n = 83) | All (n = 183) | ||
Additional SABA without a prescription from the pharmacy 12 months before the study visit | |||||||
Yes | 157 (38.8) | 75 (36.1) | 5 (35.7) | 80 (36) | 55 (55) | 22 (26.5) | 77 (42.1) |
No | 248 (61.2) | 133 (63.9) | 9 (64.3) | 142 (64) | 45 (45) | 61 (73.5) | 106 (57.9) |
Total | 405 | 208 | 14 | 222 | 100 | 83 | 183 |
Number of additional SABA 12 months before the study visit (canisters) | |||||||
1–2 | 53 (33.8) | 33 (44) | 1 (20) | 34 (42.5) | 16 (29.1) | 3 (13.6) | 19 (24.7) |
3–5 | 77 (49) | 32 (42.7) | 3 (60) | 35 (43.8) | 29 (52.7) | 13 (59.1) | 42 (54.5) |
6–9 | 21 (13.4) | 5 (6.7) | 1 (20) | 6 (7.5) | 9 (16.4) | 6 (27.3) | 15 (19.5) |
10–12 | 6 (3.8) | 5 (6.7) | 0 (0) | 5 (6.2) | 1 (1.8) | 0 (0) | 1 (1.3) |
≥ 13 | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Total | 157 | 75 | 5 | 80 | 55 | 22 | 77 |